The main event for UFC 232 at the T-Mobile Arena was thrown into jeopardy Sunday. An announcement stated a ‘very small amount‘ of the steroid commonly known as turinabol was found in headliner Jon Jones’ system. His failed test stemmed from an out of competition drug test on December 9, 2018. In response, the UFC and USADA stated that the failed test was a result of previous ingestion. Thusly falling under the purview of Jones’ 2017 suspension for the same drug.
The Business of MMA: UFC 232 Venue Change About Debt, Not Drugs
